Clinical characteristics of intraductal papillary mucinous neoplasm manifesting as acute pancreatitis or acute recurrent pancreatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 4, 2013, Pages 731-738

  Jang, Ji Woong ^a   Kim, Myung Hwan ^b   Jeong, Seung Uk ^b   Kim, Jeongseok ^b   Park, Do Hyun ^b   Lee, Sang Soo ^b   Seo, Dong Wan ^b   Lee, Sung Koo ^b   Kim, Jin Hee ^b  

^a Eulji University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Acute pancreatitis; Acute recurrent pancreatitis; Intraductal papillary mucinous neoplasm

Indexed keywords

ACUTE PANCREATITIS; ACUTE RECURRENT PANCREATITIS; ADULT; ARTICLE; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

EID: 84875599414     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12121     Document Type: Article

References (34)

1. Tsutsumi K, Ohtsuka T, Oda Y etal. A history of acute pancreatitis in intraductal papillary mucinous neoplasms of the pancreas is a potential predictive factor for malignant papillary subtype. Pancreatology 2010; 10: 707-712.
2. Cone MM, Rea JD, Diggs BS, Douthit MA, Billingsley KG, Sheppard BC. Predicting malignant intraductal papillary mucinous neoplasm: a single-center review. Am. J. Surg. 2011; 201: 575-579.
3. Takuma K, Kamisawa T, Anjiki H etal. Predictors of malignancy and natural history of main-duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2011; 40: 371-375.
4. Akita H, Takeda Y, Hoshino H etal. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery. Am. J. Surg. 2011; 202: 214-219.
5. Moriya T, Hashimoto Y, Traverso LW. The duration of symptoms predicts the presence of malignancy in 210 resected cases of pancreatic intraductal papillary mucinous neoplasms. J. Gastrointest. Surg. 2011; 15: 762-770; discussion 70-1.
6. Kang MJ, Jang JY, Kim SJ etal. Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin. Gastroenterol. Hepatol. 2011; 9: 87-93.
7. Venkatesh PG, Navaneethan U, Vege SS. Intraductal papillary mucinous neoplasm and acute pancreatitis. J. Clin. Gastroenterol. 2011; 45: 755-758.
8. Braganza JM, Lee SH, McCloy RF, McMahon MJ. Chronic pancreatitis. Lancet 2011; 377: 1184-1197.
9. Dahan P, Andant C, Levy P etal. Prospective evaluation of endoscopic ultrasonography and microscopic examination of duodenal bile in the diagnosis of cholecystolithiasis in 45 patients with normal conventional ultrasonography. Gut 1996; 38: 277-281.
10. Levy P, Boruchowicz A, Hastier P etal. Diagnostic criteria in predicting a biliary origin of acute pancreatitis in the era of endoscopic ultrasound: multicentre prospective evaluation of 213 patients. Pancreatology 2005; 5: 450-456.
11. Carnaille B, Oudar C, Pattou F, Combemale F, Rocha J, Proye C. Pancreatitis and primary hyperparathyroidism: forty cases. Aust. N. Z. J. Surg. 1998; 68: 117-119.
12. Kim HJ, Kim MH, Bae JS, Lee SS, Seo DW, Lee SK. Idiopathic acute pancreatitis. J. Clin. Gastroenterol. 2003; 37: 238-250.
13. Nahon UK, Levy P, O'Toole D etal. Is idiopathic chronic pancreatitis an autoimmune disease? Clin. Gastroenterol. Hepatol. 2005; 3: 903-909.
14. Tanaka M, Chari S, Adsay V etal. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6: 17-32.
15. Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH. Histological typing of tumors of the exocrine pancreas. In: Haank D, ed. World Health Organization International Histologic Classification of Tumors, 2nd edn. Berlin: Springer-Verlag, 1982; 237-240.
16. Solcia E, Capella C, Kloppel G. Armed Forces Institute of Pathology. In: Caton M, ed. Atlas of Tumor Pathology: Tumors of the Pancreas, 3rd edn. Washington, DC: American Registry of Pathology in collaboration with Armed Forces Institute of Pathology, 1997; 19-31.
17. Wiesenauer CA, Schmidt CM, Cummings OW etal. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch. Surg. 2003; 138: 610-617; discussion 7-8.
18. Salvia R, Fernandez-del Castillo C, Bassi C etal. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann. Surg. 2004; 239: 678-685; discussion 85-7.
19. Kim SC, Park KT, Lee YJ etal. Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J. Hepatobiliary Pancreat. Surg. 2008; 15: 183-188.
20. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174: 331-336.
21. Chatzicostas C, Roussomoustakaki M, Vardas E, Romanos J, Kouroumalis EA. Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II and III scoring systems in predicting acute pancreatitis outcome. J. Clin. Gastroenterol. 2003; 36: 253-260.
22. Casas JD, Diaz R, Valderas G, Mariscal A, Cuadras P. Prognostic value of CT in the early assessment of patients with acute pancreatitis. AJR Am. J. Roentgenol. 2004; 182: 569-574.
23. Schmidt CM, White PB, Waters JA etal. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann. Surg. 2007; 246: 644-651; discussion 51-4.
24. Kobari M, Egawa S, Shibuya K etal. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch. Surg. 1999; 134: 1131-1136.
25. Rodriguez JR, Salvia R, Crippa S etal. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 2007; 133: 72-79; quiz 309-10.
26. Kimura W, Sasahira N, Yoshikawa T, Muto T, Makuuchi M. Duct-ectatic type of mucin producing tumor of the pancreas-new concept of pancreatic neoplasia. Hepatogastroenterology 1996; 43: 692-709.
27. Pelletier AL, Hammel P, Rebours V etal. Acute pancreatitis in patients operated on for intraductal papillary mucinous neoplasms of the pancreas: frequency, severity, and clinicopathologic correlations. Pancreas 2010; 39: 658-661.
28. Fernandez-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch. Surg. 2003; 138: 427-3; discussion 33-4.
29. Tanaka M, Kobayashi K, Mizumoto K, Yamaguchi K. Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J. Gastroenterol. 2005; 40: 669-675.
30. Retter J, Dinter D, Bersch C, Singer MV, Lohr M. Acute recurrent pancreatitis curtaining an intraductal papillary mucinous tumor of the pancreas. J. Gastrointestin. Liver Dis. 2007; 16: 445-447.
31. Ringold DA, Shroff P, Sikka SK etal. Pancreatitis is frequent among patients with side-branch intraductal papillary mucinous neoplasia diagnosed by EUS. Gastrointest. Endosc. 2009; 70: 488-494.
32. Rivera JA, Fernandez-del Castillo C, Pins M etal. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity. Ann. Surg. 1997; 225: 637-644; discussion 44-6.
33. Shin SH, Han DJ, Park KT, Kim YH, Park JB, Kim SC. Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas. World J. Surg. 2010; 34: 776-783.
34. Tanaka M, Fernandez-del Castillo C, Adsay V etal. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12: 183-197.